We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$510M
AUM Growth
+$54.5M
Cap. Flow
+$16.8M
Cap. Flow %
3.3%
Top 10 Hldgs %
51.22%
Holding
322
New
62
Increased
102
Reduced
99
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Financials 5.1%
3 Consumer Discretionary 2.98%
4 Communication Services 2.94%
5 Healthcare 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
226
Biogen
BIIB
$29.9B
$223K 0.04%
1,779
+284
+19% +$35.4K
DUK icon
227
Duke Energy
DUK
$102B
$222K 0.04%
1,878
+160
+9% +$18.9K
CRWD icon
228
CrowdStrike
CRWD
$187B
$221K 0.04%
+1,736
New +$188K
GWRE icon
229
Guidewire Software
GWRE
$11.5B
$221K 0.04%
+938
New +$202K
SAN icon
230
Banco Santander
SAN
$194B
$220K 0.04%
26,528
+10,311
+64% +$76.7K
MS icon
231
Morgan Stanley
MS
$337B
$220K 0.04%
+1,562
New +$192K
HAL icon
232
Halliburton
HAL
$27.9B
$219K 0.04%
+10,735
New +$225K
SBAC icon
233
SBA Communications
SBAC
$18.4B
$217K 0.04%
+922
New +$211K
BUD icon
234
AB InBev
BUD
$158B
$216K 0.04%
+3,140
New +$211K
CCEP icon
235
Coca-Cola Europacific Partners
CCEP
$46.5B
$216K 0.04%
+2,328
New +$209K
ICE icon
236
Intercontinental Exchange
ICE
$82.4B
$215K 0.04%
+1,173
New +$202K
NEM icon
237
Newmont
NEM
$98.2B
$215K 0.04%
+3,690
New +$197K
AXP icon
238
American Express
AXP
$223B
$214K 0.04%
672
-759
-53% -$214K
BMY icon
239
Bristol-Myers Squibb
BMY
$127B
$214K 0.04%
4,613
-2,385
-34% -$117K
ACN icon
240
Accenture
ACN
$89.9B
$212K 0.04%
+711
New +$217K
PANW icon
241
Palo Alto Networks
PANW
$264B
$212K 0.04%
1,037
-1,172
-53% -$218K
NEE icon
242
NextEra Energy
NEE
$187B
$208K 0.04%
2,990
-624
-17% -$43.3K
LOW icon
243
Lowe's Companies
LOW
$116B
$207K 0.04%
933
-281
-23% -$62.7K
DINO icon
244
HF Sinclair
DINO
$15.9B
$206K 0.04%
+5,023
New +$173K
WM icon
245
Waste Management
WM
$95.9B
$205K 0.04%
+894
New +$207K
CVS icon
246
CVS Health
CVS
$137B
$204K 0.04%
2,955
-1,536
-34% -$101K
SMFG icon
247
Sumitomo Mitsui Financial
SMFG
$166B
$204K 0.04%
13,491
+3,337
+33% +$48K
EME icon
248
Emcor
EME
$33.1B
$204K 0.04%
+381
New +$168K
DD icon
249
DuPont de Nemours
DD
$18.6B
$204K 0.04%
+2,367
New +$197K
MANH icon
250
Manhattan Associates
MANH
$8.97B
$204K 0.04%
+1,031
New +$187K

Similar funds

Capital Performance Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Capital Performance Advisors held 322 positions worth $510M, up 12% from $456M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Capital Performance Advisors deployed $16.8M of net new capital in Q2 2025, opening 62 new positions and adding to 102 existing holdings. Its largest new stake was Invesco QQQ Trust: 3,857 shares worth $2.13M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $850K trimmed.

  • Capital Performance Advisors's largest Q2 2025 buy was Invesco QQQ Trust: 3,857 shares worth $2.13M.
  • Capital Performance Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $6.21M increase.
  • Capital Performance Advisors's biggest Q2 2025 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $850K.
  • Capital Performance Advisors fully exited KalVista Pharmaceuticals in Q2 2025, selling an estimated $1.8M.
  • Capital Performance Advisors's ten largest holdings make up 51% of its $510M portfolio in Q2 2025.
  • Capital Performance Advisors opened 62 new positions and closed 50 in Q2 2025.
  • Capital Performance Advisors's portfolio value rose 12% quarter-over-quarter to $510M.

Based on Capital Performance Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.